State of Alaska Department of Revenue Grows Position in Cooper Companies Inc (NYSE:COO)

State of Alaska Department of Revenue boosted its stake in shares of Cooper Companies Inc (NYSE:COO) by 150.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 38,126 shares of the medical device company’s stock after purchasing an additional 22,911 shares during the period. State of Alaska Department of Revenue owned about 0.08% of Cooper Companies worth $11,322,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in COO. Ossiam purchased a new position in Cooper Companies during the second quarter valued at $25,000. Flagship Harbor Advisors LLC lifted its position in Cooper Companies by 62.5% during the second quarter. Flagship Harbor Advisors LLC now owns 78 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 30 shares in the last quarter. Kings Point Capital Management purchased a new position in Cooper Companies during the second quarter valued at $27,000. Evolution Wealth Advisors LLC purchased a new position in Cooper Companies during the second quarter valued at $34,000. Finally, NumerixS Investment Technologies Inc purchased a new position in shares of Cooper Companies in the second quarter valued at about $34,000. Institutional investors own 95.71% of the company’s stock.

Shares of NYSE:COO traded up $3.12 during mid-day trading on Friday, reaching $296.87. The stock had a trading volume of 417,455 shares, compared to its average volume of 329,244. The company has a current ratio of 1.29, a quick ratio of 0.73 and a debt-to-equity ratio of 0.39. The company has a market cap of $14.52 billion, a P/E ratio of 25.81, a price-to-earnings-growth ratio of 2.30 and a beta of 0.91. Cooper Companies Inc has a 1 year low of $228.65 and a 1 year high of $344.32. The business’s 50 day moving average price is $309.30 and its 200 day moving average price is $309.95.

Cooper Companies (NYSE:COO) last posted its earnings results on Thursday, August 29th. The medical device company reported $3.23 EPS for the quarter, topping analysts’ consensus estimates of $3.16 by $0.07. The company had revenue of $679.40 million for the quarter, compared to the consensus estimate of $687.60 million. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the previous year, the business earned $3.00 earnings per share. Analysts predict that Cooper Companies Inc will post 12.32 earnings per share for the current fiscal year.

Several equities analysts have recently commented on COO shares. Zacks Investment Research upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 price objective on the stock in a research report on Friday, June 7th. Wells Fargo & Co boosted their price objective on Cooper Companies from $356.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. KeyCorp set a $351.00 price objective on Cooper Companies and gave the company a “buy” rating in a research report on Friday, August 30th. Piper Jaffray Companies set a $360.00 price objective on Cooper Companies and gave the company a “buy” rating in a research report on Friday, August 30th. Finally, ValuEngine downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Tuesday, September 10th. One analyst has rated the stock with a sell rating, two have given a hold rating and ten have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $326.27.

In related news, Director Allan E. Rubenstein sold 1,335 shares of the business’s stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $299.61, for a total value of $399,979.35. Following the sale, the director now directly owns 3,591 shares in the company, valued at $1,075,899.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.70% of the stock is currently owned by insiders.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Article: Real Estate Investment Trust (REIT) ETF

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.